MX351980B - Método y dispositivo para la disolucion rápida de composición sólida de proteinas solidas. - Google Patents

Método y dispositivo para la disolucion rápida de composición sólida de proteinas solidas.

Info

Publication number
MX351980B
MX351980B MX2014008033A MX2014008033A MX351980B MX 351980 B MX351980 B MX 351980B MX 2014008033 A MX2014008033 A MX 2014008033A MX 2014008033 A MX2014008033 A MX 2014008033A MX 351980 B MX351980 B MX 351980B
Authority
MX
Mexico
Prior art keywords
protein composition
solid protein
solid
pressure
fast dissolution
Prior art date
Application number
MX2014008033A
Other languages
English (en)
Other versions
MX2014008033A (es
Inventor
Israel Nur
Moti Meron
Erez Ilan
Kfir Regev
Dana Leitman
John Goodman
Original Assignee
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL217273A external-priority patent/IL217273A0/en
Application filed by Omrix Biopharmaceuticals Ltd filed Critical Omrix Biopharmaceuticals Ltd
Publication of MX2014008033A publication Critical patent/MX2014008033A/es
Publication of MX351980B publication Critical patent/MX351980B/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/50—Mixing liquids with solids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
    • B01F25/451—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by means for moving the materials to be mixed or the mixture
    • B01F25/4512—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by means for moving the materials to be mixed or the mixture with reciprocating pistons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/25—Mixers with loose mixing elements, e.g. loose balls in a receptacle
    • B01F33/251—Mixers with loose mixing elements, e.g. loose balls in a receptacle using balls as loose mixing element
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/50—Movable or transportable mixing devices or plants
    • B01F33/501—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use
    • B01F33/5011—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held
    • B01F33/50112—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held of the syringe or cartridge type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/71—Feed mechanisms
    • B01F35/716—Feed mechanisms characterised by the relative arrangement of the containers for feeding or mixing the components
    • B01F35/7163—Feed mechanisms characterised by the relative arrangement of the containers for feeding or mixing the components the containers being connected in a mouth-to-mouth, end-to-end disposition, i.e. the openings are juxtaposed before contacting the contents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/71—Feed mechanisms
    • B01F35/717—Feed mechanisms characterised by the means for feeding the components to the mixer
    • B01F35/718—Feed mechanisms characterised by the means for feeding the components to the mixer using vacuum, under pressure in a closed receptacle or circuit system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se proveen métodos y dispositivos para disolver composiciones proteicas sólidas, tales como composiciones sólidas que contienen fibrinógeno, en un solvente acuoso; los métodos comprenden el uso de un contenedor cerrado que contiene un volumen de composición sólida de fibrinógeno y un espacio libre superior, en que la presión dentro del espacio libre superior es subatmosférica; se introduce solvente acuoso al contenedor mientras se mantiene la presión subatmosférica y, en seguida de la adición del solvente, se disminuye el tamaño del espacio libre superior para convertir la presión en presión atmosférica; los dispositivos son adecuados para su uso en el método descrito.
MX2014008033A 2011-12-29 2012-12-20 Método y dispositivo para la disolucion rápida de composición sólida de proteinas solidas. MX351980B (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL217273A IL217273A0 (en) 2011-12-29 2011-12-29 Fast dissolution of solid fibrinogen
US201261582524P 2012-01-03 2012-01-03
US201261677048P 2012-07-30 2012-07-30
IL22118012 2012-07-30
PCT/IL2012/000393 WO2013098805A1 (en) 2011-12-29 2012-12-20 Method and device for fast dissolution of solid protein composition

Publications (2)

Publication Number Publication Date
MX2014008033A MX2014008033A (es) 2014-12-08
MX351980B true MX351980B (es) 2017-11-03

Family

ID=48696437

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014008033A MX351980B (es) 2011-12-29 2012-12-20 Método y dispositivo para la disolucion rápida de composición sólida de proteinas solidas.

Country Status (14)

Country Link
US (2) US10618950B2 (es)
EP (1) EP2797681B1 (es)
JP (1) JP6223999B2 (es)
KR (1) KR102109317B1 (es)
AU (1) AU2012360048B2 (es)
BR (1) BR112014016193A8 (es)
CA (2) CA2861722C (es)
ES (1) ES2621363T3 (es)
HK (1) HK1203438A1 (es)
IL (1) IL233361B (es)
IN (1) IN2014DN05901A (es)
MX (1) MX351980B (es)
RU (1) RU2605710C2 (es)
WO (1) WO2013098805A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014016193A8 (pt) 2011-12-29 2017-07-04 Omrix Biopharmaceuticals Ltd método e dispositivo para dissilução rápida
ES2916825T3 (es) 2014-01-20 2022-07-06 UCB Biopharma SRL Procedimiento para la reconstitución de una forma sólida de una composición farmacéutica
US20170274012A1 (en) * 2014-09-03 2017-09-28 Entegrion, Inc. Acceleration of Reconstitution of Plasma Powder by Mixing with Small Beads
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
USD829888S1 (en) * 2015-12-22 2018-10-02 Guangzhou Bioseal Biotech Co., Ltd. Reconstitution and delivery device
US10918790B2 (en) * 2015-12-22 2021-02-16 Guangzhou Bioseal Biotech Co., Ltd. Dual syringe with funnel feeding kit
USD877891S1 (en) 2015-12-22 2020-03-10 Guangzhou Bioseal Biotech Co., Ltd. Reconstitution and delivery device
USD877890S1 (en) 2015-12-22 2020-03-10 Guangzhou Bioseal Biotech Co., Ltd. Reconstitution device
IL244922A0 (en) 2016-04-05 2016-07-31 Omrix Biopharmaceuticals Ltd Device and method for sample preparation
WO2017184880A1 (en) 2016-04-20 2017-10-26 Coherus Biosciences, Inc. A method of filling a container with no headspace
US10150115B2 (en) * 2016-07-21 2018-12-11 Spacepharma SA System and method for rehydrating powder and delivering the rehydrated powder to a reactor
WO2018150375A1 (en) * 2017-02-17 2018-08-23 Baxter International Inc. Devices and methods for forming and delivering a tissue sealant
CA3010633A1 (en) * 2017-07-06 2019-01-06 Plas-Tech Engineering, Inc. Systems and methods related to fluid pumping
WO2023119277A1 (en) 2021-12-21 2023-06-29 Omrix Biopharmaceuticals Ltd. Highly soluble fibrinogen compositions

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052240A (en) * 1959-01-29 1962-09-04 Silver Disposable hypodermic syringe
US3405712A (en) * 1966-02-07 1968-10-15 Richard L. Pierick Desiccative syringe
AT366916B (de) * 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
AT371719B (de) 1980-08-25 1983-07-25 Immuno Ag Verfahren und vorrichtung zur beschleunigung des aufloesens von schwerloeslichen lyophilisierten arzneimitteln
DE3203775A1 (de) 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
US4610666A (en) * 1985-06-24 1986-09-09 Pizzino Joanne L Dual syringe
US4742128A (en) * 1985-10-15 1988-05-03 Stamicarbon B.V. Process for preparing a polymer alloy, molded product, and reaction injection molded products
US4978336A (en) * 1987-09-29 1990-12-18 Hemaedics, Inc. Biological syringe system
AT397203B (de) 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
AT392972B (de) 1988-08-16 1991-07-25 Chemiefaser Lenzing Ag Verfahren zur herstellung von loesungen von cellulose sowie einrichtung zur durchfuehrung des verfahrens
SU1697836A1 (ru) 1989-01-24 1991-12-15 Московский научно-исследовательский онкологический институт им.П.А.Герцена Устройство дл смешивани и введени жидких быстроструктурирующихс компонентов
US5122117A (en) * 1990-06-05 1992-06-16 Habley Medical Technology Corp. Component mixing syringe
US5181909A (en) * 1991-05-15 1993-01-26 Mcfarlane Richard H Ampule-container medical syringe and methods
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
EP0534178B1 (en) 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Improved tissue glue prepared by using cryoprecipitate
JP3063935B2 (ja) 1992-05-12 2000-07-12 宇部興産株式会社 接着性、耐熱性および耐カ−ル性を兼ね備えたポリイミドシロキサン組成物
US5599790A (en) * 1992-06-11 1997-02-04 The Scripps Research Institute Fibrinogen γ chain polypeptide and compositions thereof
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
AT400675B (de) * 1993-10-18 1996-02-26 Immuno Ag Spritzengarnitur zur aufbewahrung und applikation eines mehrkomponentenmaterials, spritzenvorrichtung und betätigungseinrichtung hiefür sowie verfahren zum herstellen einer befüllten, sterilen spritzenvorrichtung
US6965014B1 (en) * 1996-01-16 2005-11-15 Baxter International Inc. Fibrin material and method for producing and using the same
US6599515B1 (en) * 1995-01-16 2003-07-29 Baxter International Inc. Fibrin porous structure
DK0835667T3 (da) * 1996-03-15 2005-12-05 Chemo Sero Therapeut Res Inst Vævklæbemiddel egnet til spröjtepåföring
DE19617369A1 (de) 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
FR2749169B1 (fr) 1996-06-04 1998-08-21 Delab Procede pour constituer une preparation injectable et dispositif pour la mise en oeuvre de ce procede
JP3063935U (ja) 1999-05-17 1999-12-10 川澄化学工業株式会社 二液同時混合注出器及びプランジャ結合部材
AU2001287023A1 (en) * 2000-09-01 2002-03-13 Virginia Commonwealth University Intellectual Property Foundation Plasma-derived-fibrin-based matrices and tissue
WO2002095019A1 (en) 2001-05-21 2002-11-28 Omrix Biopharmaceuticals S.A. Removal of plasmin(ogen) from protein solutions
DE10211227A1 (de) 2002-03-13 2003-10-02 Aventis Behring Gmbh Verfahren zur Rekonstitution von Iyophilisierten Proteinen
EP1545994B1 (en) * 2002-08-21 2006-11-15 Pharmacia Corporation Injectable pharmaceutical suspension in a two-chamber vial
DE20216631U1 (de) 2002-10-28 2004-03-11 Haindl, Hans, Dr.med. Selbstentlüftende Spritze für das Mischen von flüssigen und pulverförmigen Substanzen
WO2004067704A2 (en) * 2003-01-30 2004-08-12 Prochon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
US6669667B1 (en) * 2003-04-11 2003-12-30 Jih-Hsiung Yang Safety syringe
SI1646659T1 (sl) * 2003-06-23 2014-07-31 Kiacta Sarl Postopek za pripravo spojin 1,3-propan disulfonske kisline
DE102005017985A1 (de) 2005-04-19 2006-10-26 Theo Arnitz Verfahren und Vorrichtungen zum Auflösen von Medikamenten für Injektionen
WO2006124634A1 (en) * 2005-05-16 2006-11-23 Mallinckrodt Inc. Multi-barrel syringe having integral manifold
ES2348940T3 (es) 2006-01-17 2010-12-17 Baxter International Inc. Dispositivo, sistema y método de mezcla.
DE102006009611A1 (de) 2006-03-02 2007-09-06 Bernd Hansen System zum Zubereiten und Bereitstellen eines durch Vermischen einer Trockensubstanz mit einem Fluid gebildeten fließfähigen Mediums
JP5373618B2 (ja) 2006-11-02 2013-12-18 オムリクス バイオファーマシューティカルズ リミテッド 微粒化方法
US20080221584A1 (en) * 2007-03-06 2008-09-11 Downer David A Lens Delivery System
CN101678086B (zh) 2007-03-22 2013-07-10 财团法人化学及血清疗法研究所 固体纤维蛋白原制剂
DE102008003103A1 (de) 2008-01-01 2009-07-02 Lts Lohmann Therapie-Systeme Ag Einweginjektor mit zweikolbigem Zweikammersystem
US20090198211A1 (en) * 2008-02-06 2009-08-06 Intravena, Llc Convenience IV kits and methods of use
US8512740B2 (en) * 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
JP5264545B2 (ja) 2008-06-16 2013-08-14 テルモ株式会社 液体混合方法
JP5318684B2 (ja) 2009-07-14 2013-10-16 テルモ株式会社 シリンジおよびシリンジ連結体
WO2011031783A1 (en) * 2009-09-08 2011-03-17 Baxter International Inc. Reconstitution and applicator system for wound sealant product
BR112014016193A8 (pt) 2011-12-29 2017-07-04 Omrix Biopharmaceuticals Ltd método e dispositivo para dissilução rápida

Also Published As

Publication number Publication date
JP6223999B2 (ja) 2017-11-01
IL233361B (en) 2018-06-28
RU2014131276A (ru) 2016-02-20
US11634473B2 (en) 2023-04-25
WO2013098805A1 (en) 2013-07-04
CA3078563A1 (en) 2013-07-04
RU2605710C2 (ru) 2016-12-27
CA2861722C (en) 2020-06-30
IN2014DN05901A (es) 2015-06-05
US10618950B2 (en) 2020-04-14
KR20140108709A (ko) 2014-09-12
HK1203438A1 (en) 2015-10-30
BR112014016193A8 (pt) 2017-07-04
CN104144742A (zh) 2014-11-12
IL233361A0 (en) 2014-08-31
US20130312868A1 (en) 2013-11-28
EP2797681B1 (en) 2017-02-01
JP2015509084A (ja) 2015-03-26
ES2621363T3 (es) 2017-07-03
US20200262892A1 (en) 2020-08-20
KR102109317B1 (ko) 2020-05-29
MX2014008033A (es) 2014-12-08
AU2012360048B2 (en) 2017-05-25
BR112014016193A2 (pt) 2017-06-13
AU2012360048A1 (en) 2014-08-14
CA2861722A1 (en) 2013-07-04
EP2797681A1 (en) 2014-11-05

Similar Documents

Publication Publication Date Title
MX2014008033A (es) Método y dispositivo para la disolucion rápida de composición sólida de proteinas solidas.
EP2677029A3 (en) Methods for the manufacture of proteolytically processed polypeptides
WO2012121523A3 (en) Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection containing pemetrexed or its salt
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
WO2012162259A3 (en) Caps for cannula access devices
GB2508777A (en) Polymeric material for an insulated container
EP3070163A4 (en) Method for preparing induced pluripotent stem cell, composition used in method, and uses thereof
EP3037523A4 (en) Production method and cryopreservation method for amniotic mesenchymal cell composition, and therapeutic agent
WO2015044782A3 (en) Intranasal dhe for the treatment of headache
MX2016008662A (es) Composicion farmaceutica que no contiene antioxidantes y metodo de preparacion de la misma.
SI2374353T1 (sl) Postopek za konzerviranje vodnih pripravkov mineralnih materialov, konzervirani vodni pripravki mineralnih materialov in uporaba konzervirnih spojin v vodnih pripravkih mineralnih materialov
JO3362B1 (ar) الحفظ بالتبريد لخلايا سرطان الموت الخلوي المبرمج للاستعمال في العلاج المناعي ضد السرطان
EP3225620A4 (en) Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition containing same
MY164159A (en) Liquid tobacco compositions
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
MX358132B (es) Solucion de trombina y metodos de uso de esta.
MX2016009347A (es) Proceso para la reconstitucion de una forma solida de una composicion farmaceutica.
WO2014001297A3 (en) Preparation of composition comprising gas microbubbles
CA2911044C (fr) Procede de stabilisation d'une composition contenant au moins un produit de deshydratation interne d'un sucre hydrogene, composition obtenue et ses utilisations
NZ717101A (en) Partial melt co-crystallization compositions
MX2014013218A (es) Metodo para llenar un contenedor con una composicion espumable.
EP3082801A4 (en) An advanced and cost-effective process for preparing highly pure vildagliptin
AU2013338098A8 (en) Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
PT2733086E (pt) Máquina de fabricação de corpos de aglomerado de cortiça, em particular rolhas destinadas a serem utilizadas no campo enológico
MX2015017198A (es) Matriz.

Legal Events

Date Code Title Description
FG Grant or registration